Oura pulls IPO hours before pricing
San Francisco smart-ring maker Oura delayed its September 2026 IPO, citing market uncertainty and a valuation target exceeding $11 billion.
Mateo Fernandez ·
[No SEC filing or formal pricing notice cited in the source; valuation claim is single-sourced to the company; no market reaction figures or independent expert quotes available]
Oura Health pulled its planned IPO on September 29, 2026, citing "uncertainty in the IPO market" after pitching a valuation above $11 billion, the company said, delaying its public debut.
IPO timing and valuation
The San Francisco startup said it had paused the listing late on September 29, 2026, telling investors it would not proceed as scheduled because market conditions had shifted. Officials said the decision came after the company gauged demand for the deal and concluded the timing was not right; the source did not include a regulatory filing or a new timetable.
Company representatives framed the move as a pause rather than a cancellation. Officials said the firm had marketed the offering at price levels that implied a valuation above $11 billion, a figure provided by the company and not independently verified in the source.
Watch for any refiling by December 31, 2026. That deadline will be the next clear test of whether Oura returns to market windows that investors consider more favorable; absent a new filing, the company’s public debut could be pushed into 2027.